TY - JOUR PY - 2017// TI - Marijuana use trajectories among drug-using youth presenting to an urban emergency department: violence and social influences JO - Drug and alcohol dependence A1 - Walton, Maureen A. L. A1 - Epstein-Ngo, Quyen A1 - Carter, Patrick M. A1 - Zimmerman, Marc A. A1 - Blow, Frederic C. A1 - Buu, Anne A1 - Goldstick, Jason A1 - Cunningham, Rebecca M. SP - 117 EP - 125 VL - 173 IS - N2 - AIMS: This paper examined longitudinal marijuana use trajectories among drug-using youth presenting to the ED to inform intervention development.

METHODS: Given interest in substance use and violence, this study oversampled those presenting with assault injuries. Assault-injured youth (ages 14-24) endorsing past 6-month drug use (n=349), and a sex and age proportionally-sampled comparison group (n=250) endorsing drug use, completed a baseline assessment and follow-ups at 6, 12, 18, and 24 months. Latent class trajectory analyses examined days of marijuana use over 2 years. Multinomial regression analyses examined baseline, 12-month and 24-month factors associated with substance use trajectory groups.

RESULTS: Trajectory analyses identified 5 groups: Low (Low; 28.2%; n=169); Intermittent (INT; 16.2%; n=97); Moderate Decline (MD; 12.0%; n=72); High decline (HD, 13.2%; n=79) and Chronic (C; 30.4%; n=182). At baseline, as compared to the Low group, the other trajectory groups were more likely to be male and have greater levels of physical aggression. At 12- and 24-months, negative and positive peer influences, incarceration and community violence were additional characteristics associated with the greater marijuana use trajectories (as compared to the Low group).

CONCLUSIONS: Interventions for drug-using youth presenting to the urban ED should address peer influences, physical aggression and community violence exposure, given the association between these characteristics and greater marijuana use trajectories.

Copyright © 2017 Elsevier B.V. All rights reserved.

Language: en

LA - en SN - 0376-8716 UR - http://dx.doi.org/10.1016/j.drugalcdep.2016.11.040 ID - ref1 ER -